Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline von Tung, Nadine M., Boughey, Judy C., Pierce, Lori J., Robson, Mark E., Bedrosian, Isabelle, Dietz, Jill R., Dragun, Anthony, Gelpi, Judith Balmana, Hofstatter, Erin W., Isaacs, Claudine J., Jatoi, Ismail, Kennedy, Elaine, Litton, Jennifer K., Mayr, Nina A., Qamar, Rubina D., Trombetta, Mark G., Harvey, Brittany E., Somerfield, Mark R., Zakalik, Dana

Volltext

Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline von Rathmell, W. Kimryn, Rumble, R. Bryan, Van Veldhuizen, Peter J., Al-Ahmadie, Hikmat, Emamekhoo, Hamid, Hauke, Ralph J., Louie, Alexander V., Milowsky, Matthew I., Molina, Ana M., Rose, Tracy L., Siva, Shankar, Zaorsky, Nicholas G., Zhang, Tian, Qamar, Rubina, Kungel, Terry M., Lewis, Bryan, Singer, Eric A.

Volltext

Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance) von LOPRINZI, Charles L, RUI QIN, DAKHIL, Shaker R, FEHRENBACHER, Louis, FLYNN, Kathleen A, ATHERTON, Pamela, SEISLER, Drew, QAMAR, Rubina, LEWIS, Grant C, GROTHEY, Axel

Volltext

MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial von Soliman, Hatem, Shah, Varsha, Srkalovic, Gordan, Mahtani, Reshma, Levine, Ellis, Mavromatis, Blanche, Srinivasiah, Jayanthi, Kassar, Mohamad, Gabordi, Robert, Qamar, Rubina, Untch, Sarah, Kling, Heather M., Treece, Tina, Audeh, William

Volltext

Use of Echocardiography to Evaluate the Cardiac Effects of Therapies Used in Cancer Treatment: What Do We Know? von Oreto, Lilia, MD, Todaro, Maria Chiara, MD, Umland, Matt M., RDCS, FASE, Kramer, Christopher, RDCS, Qamar, Rubina, MD, Carerj, Scipione, MD, FESC, Khandheria, Bijoy K., MD, FACC, FESC, FASE, FAHA, FACP, Paterick, Timothy E., MD, JD, FASE, FACC

Volltext

Multimodality Imaging in Cardiooncology von Khandheria, Bijoy K., Carerj, Scipione, Bomzer, Charles, Qamar, Rubina, Vizzari, Giampiero, Pizzino, Fausto, Zito, Concetta

Volltext

Risk factors of trastuzumab-induced cardiotoxicity in breast cancer: A meta-analysis von Jawa, Zeeshan, Perez, Ruth M., Garlie, Lydia, Singh, Maharaj, Qamar, Rubina, Khandheria, Bijoy K., Jahangir, Arshad, Shi, Yang

Volltext

Diagnosis of Chemotherapy-Induced Cardiotoxicity von Vizzari, Giampiero, Carerj, Scipione, Qamar, Rubina, Pizzino, Fausto, Zito, Concetta, Khandheria, Bijoy K, Bomzer, Charles A

Volltext

Management of Metastatic Renal Clear Cell Cancer: ASCO Guideline Rapid Recommendation Update von Singer, Eric A., Rumble, R. Bryan, Rathmell, W. Kimryn, Van Veldhuizen, Peter J., Kimryn Rathmell, W., Van Veldhuizen, Peter J., Bryan Rumble, R., Al-Ahmadie, Hikmat, Emamekhoo, Hamid, Hauke, Ralph J., Louie, Alexander V., Milowsky, Matthew I., Molina, Ana M., Rose, Tracy L., Siva, Shankar, Zaorsky, Nicholas G., Zhang, Tian, Qamar, Rubina, Kungel, Terry M., Lewis, Bryan, Singer, Eric A.

Volltext

Circulating tumor cells (CTCs) dynamics after CDK4/6i for hormone-receptor positive (HR+) metastatic breast cancer (MBC): A biomarker analysis of the PACE randomized phase II study von Gerratana, Lorenzo, Ren, Yue, Reduzzi, Carolina, Regan, Meredith M., Mahtani, Reshma L., Ma, Cynthia X., DeMichele, Angela, Meisel, Jane Lowe, Miller, Kathy, Jolly, Trevor Augustus, Riley, Elizabeth Carloss, Qamar, Rubina, Sharma, Priyanka, Reid, Sonya A., Ko, Naomi Yu, Liu, Yuan, Burstein, Harold J., Tolaney, Sara M., Cristofanilli, Massimo, Mayer, Erica L.

Volltext

Abstract P2-14-11: Treatment recommendations in ER+ patients ≤ 50 years: Comparison of the 21-gene assay and 70-gene signature in the PROMIS study von Tsai, Michaela, Soliman, Hatem, Lo, Shelly, Qamar, Rubina, Budway, Raye, Levine, Ellis, Whitworth, Pat, Mavromatis, Blanche, Zon, Robin, Untch, Sarah, Blumencranz, Lisa, McKelley, Joseph, Audeh, William

Volltext

Cluster-randomized trial to evaluate the implementation of reproductive health care in cancer care delivery in community oncology practices: Results from ECOG-ACRIN E1Q11 von Patel, Ashlesha, Lee, Ju-Whei, Zaren, Howard A., Radeke, Erika K, Lerner, Rachel E., Fukui, Jami Aya, Makower, Della F., Tamkus, Deimante, Rowland, Kendrith M., Adler, William M., Throckmorton, Alyssa, Ghamande, Sharad A., Hackney, Mary Helen, Pippas, Andrew William, Qamar, Rubina, Cella, David, Fisch, Michael Jordan, Wagner, Lynne I.

Volltext

Cardioncology: State of the heart von Todaro, Maria Chiara, Oreto, Lilia, Qamar, Rubina, Paterick, Timothy E, Carerj, Scipione, Khandheria, Bijoy K

Volltext

A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B‐cell non‐Hodgkin lymphoma: A Wisconsin Oncology Network study von Fenske, Timothy S., Shah, Namrata M., Kim, Kyung Mann, Saha, Sandeep, Zhang, Chong, Baim, Arielle E., Farnen, John P., Onitilo, Adedayo A., Blank, Jules H., Ahuja, Harish, Wassenaar, Tim, Qamar, Rubina, Mansky, Patrick, Traynor, Anne M., Mattison, Ryan J., Kahl, Brad S.

Volltext

Sorafenib or Placebo with Either Gemcitabine or Capecitabine in Patients with HER-2―Negative Advanced Breast Cancer That Progressed during or after Bevacizumab von SCHWARTZBERG, Lee S, TAUER, Kurt W, BELL-MCGUINN, Katherine, KIRSHNER, Jeffrey J, EISENBERG, Peter, EMANUELSON, Richard, KEATON, Mark, LEVINE, Ellis, MEDGYESY, Diana C, QAMAR, Rubina, STARR, Alexander, SUNHEE KWON RO, HERMANN, Robert C, LOKKER, Nathalie A, HUDIS, Clifford A, MAKARI-JUDSON, Grace, ISAACS, Claudine, THADDEUS BECK, J, KAKLAMANI, Virginia, STEPANSKI, Edward J, RUGO, Hope S, WEI WANG

Volltext

Effect of metabolic syndrome on risk of recurrence and immune pathways in invasive lobular carcinoma disparately compared to ductal von Robinson, Patricia A., Treece, Tina, Osipo, Clodia, Qamar, Rubina, Zon, Robin, Levine, Ellis Glenn, Budway, Raye, Mavromatis, Blanche H., Untch, Sarah, Bernards, Rene, Audeh, M. William, Soliman, Hatem Hussein

Volltext

FERTILITY DYNAMICS AND REPRODUCTIVE HEALTH STATUS AMONG FEMALE PATIENTS WITH CANCER: INSIGHTS FROM THE ENGENDERING REPRODUCTIVE HEALTH WITHIN ONCOLOGIC SURVIVORSHIP - EROS (ECOG-AC... von Francone, Nicolás O., Lee, Ju-Whei, Radeke, Erika K., Goldman, Kara N., Moretti, Luca, Makower, Della, Fukui, Jami A., Tamkus, Deimante, Rowland, Kendrith, Adler, William, Throckmorton, Alyssa D., Ghamande, Sharad, Croley, Jessica J., Helen H Hackney, Mary, Qamar, Rubina, Cella, David, Fisch, Michael J., Wagner, Lynne, Zaren, Howard ALLEN.A., Patel, Ashlesha

Volltext

Abstract GS3-06: GS3-06 Palbociclib After CDK4/6i and Endocrine Therapy (PACE): A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab for Endocrine Pre-treated ER+/... von Mayer, Erica L., Ren, Yue, Wagle, Nikhil, Mahtani, Reshma, Ma, Cynthia, DeMichele, Angela, Cristofanilli, Massimo, Meisel, Jane, Miller, Kathy D., Jolly, Trevor, Riley, Elizabeth, Qamar, Rubina, Sharma, Priyanka, Reid, Sonya, Sinclair, Natalie, Faggen, Meredith, Block, Caroline, Ko, Naomi, Partridge, Ann, Chen, Wendy Y., DeMeo, Michelle K., Attaya, Victoria, Okpoebo, Amanda, Liu, Yuan, Gauthier, Eric, Burstein, Harold, Regan, Meredith, Tolaney, Sara

Volltext

Phase III randomized, placebo (PL)-controlled, double-blind study of intravenous calcium/magnesium (CaMg) to prevent oxaliplatin-induced sensory neurotoxicity (sNT), N08CB: An alli... von Loprinzi, Charles L., Qin, Rui, Dakhil, Shaker R., Fehrenbacher, Louis, Stella, Philip J., Atherton, Pamela J., Seisler, Drew K., Qamar, Rubina, Lewis, Grant Carlton, Grothey, Axel

Volltext

Weekly Temsirolimus and Bortezomib For Relapsed Or Refractory B-Cell Non-Hodgkin Lymphoma: A Wisconsin Oncology Network Phase II Study von Fenske, Timothy S., Kim, KyungMann, Zhang, Chong, Farnen, John P., Onitilo, Adedayo A., Blank, Jules H., Ahuja, Harish, Wassenaar, Tim, Qamar, Rubina, Mansky, Patrick, Traynor, Anne, Mattison, Ryan J., Kahl, Brad S.

Volltext